Xuemei Fu

Prof. Xuemei Fu


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2015 in Cell Transplantation
Verified
Journal Article
Open access
XFXuemei Fu
Xuemei Fu
SLSu-Juan Liu
Su-Juan Liu
QDQi-Qin Dan
Qi-Qin Dan
YWYan-Ping Wang
Yan-Ping Wang
NLNa Lin
Na Lin
TWTing-Hua Wang
Ting-Hua Wang
This study examined the role of bone mesenchymal stem cell (BMSC) and olfactory ensheathing cell (OEC) cografting on neural function and underlying molecular mechanisms in acute stage of traumatic brain injury (TBI) rats. Eighty Sprague-Dawley (SD) female rats were randomly divided into five groups ( n = 16 per category): sham operated group (Sham), weight-drop-induced TBI group (TBI), BMSC transplantation group (BMSC), OEC transplantation group (OEC), and cotransplantation group (CO). Eight rats were randomly selected from each group for behavioral and morphological assessment. Another category ( n = 8 rats) was employed in the genetic expression detection. BMSCs were isolated from GFP mice and identified by CD44 antibody. OECs were isolated from the SD rats, identified by P75 antibody and labeled by Hoechst 33342. They were then transplanted into the surrounding tissue of the epicenter of TBI rats. The result of neurological severity scores revealed that BMSC or OEC transplantation alone and BMSC and OEC cografting significantly ameliorated the neurological deficits of TBI rats. Quantitative immunohistochemical analysis showed that graft-recipient animals possessed dramatically more neurons and regenerated axons and smaller amounts of astrocytes than controls 14 days posttransplantation ( p <0.05). However, the expressional level of ciliary neurotrophic factor significantly decreased in the cografting group as determined by RT-PCR ( p <0.05), and the Janus kinase/signal transducer and activator of transcription pathway was significantly activated at 7 days after cell transplantation ( p <0.05). This study is the first to report the role of cotransplantation of BMSCs and OECs in the therapy of TBI and explore its potential molecular mechanisms, therefore providing the important morphological and molecular biological evidence for the clinical application of BMSC and/or OEC transplantation in TBI.

4 January 2024 in Transfusion
Verified
Journal Article
Closed access
MLMeng Li
Meng Li
YZYuwei Zhao
Yuwei Zhao
XCXue Chen
Xue Chen
XDXinman Du
Xinman Du
YLYue Luo
Yue Luo
XFXuemei Fu
Xuemei Fu

15 August 2020 in Transfusion
Verified
Journal Article
Closed access
PDF file
MLMeng Li
Meng Li
YZYuwei Zhao
Yuwei Zhao
YLYing Li
Ying Li
XCXue Chen
Xue Chen
DLDongxia Luo
Dongxia Luo
XFXuemei Fu
Xuemei Fu

30 September 2020 in Transfusion Medicine
Verified
Journal Article
Closed access
PDF file
PHPing Hu
Ping Hu
JKJianxun Kang
Jianxun Kang
YLYing Li
Ying Li
XLXiaochun Li
Xiaochun Li
MLMeng Li
Meng Li
XFXuemei Fu
Xuemei Fu

25 April 2024 in Transfusion
Verified
Journal Article
Closed access
XCXue Chen
Xue Chen
HLHumin Liu
Humin Liu
MLMeng Li
Meng Li
JKJianxun Kang
Jianxun Kang
YLYing Li
Ying Li
JTJingyun Tang
Jingyun Tang

14 June 2023 in Frontiers in Immunology
Verified
Journal Article
Open access
JTJingyun Tang
Jingyun Tang
HLHumin Liu
Humin Liu
QWQing Wang
Qing Wang
XGXiaobo Gu
Xiaobo Gu
JWJia Wang
Jia Wang
XCXue Chen
Xue Chen
Background: Demographic information has been shown to help predict high antibody titers of COVID-19 convalescent plasma (CCP) in CCP donors. However, there is no research on the Chinese population and little evidence on whole-blood donors. Therefore, we aimed to investigate these associations among Chinese blood donors after SARS-CoV-2 infection.Methods: In this cross-sectional study, 5,064 qualified blood donors with confirmed or suspected SARS-CoV-2 infection completed a self-reported questionnaire and underwent tests of SARS-CoV-2 Immunoglobulin G (IgG) antibody and ABO blood type. Logistic regression models were used to calculate odds ratios (ORs) for high SARS-CoV-2 IgG titers according to each factor.Results: Totally, 1,799 participants (with SARS-CoV-2 IgG titers≥1:160) had high-titer CCPs. Multivariable analysis showed that a 10-year increment in age and earlier donation were associated with higher odds of high-titer CCP, while medical personnel was associated with lower odds. The ORs (95% CIs) of high-titer CCP were 1.17 (1.10–1.23, p< 0.001) and 1.41 (1.25-1.58, p< 0.001) for each 10-year increment in age and earlier donation, respectively. The OR of high-titer CCP was 0.75 (0.60-0.95, p = 0.02) for medical personnel. Female early donors were associated with increased odds of high-titer CCP, but this association was insignificant for later donors. Donating after 8 weeks from the onset was associated with decreased odds of having high-titer CCP compared to donating within 8 weeks from the onset, and the HR was 0.38 (95% CI: 0.22-0.64, p <0.001). There was no significant association between ABO blood type or race and the odds of high-titer CCP.Discussion: Older age, earlier donation, female early donors, and non-medical-related occupations are promising predictors of high-titer CCP in Chinese blood donors. Our findings highlight the importance of CCP screening at the early stage of the pandemic.